| 1. |
Blackham KA, Meyers PM, Abruzzo TA, et al. Endovascular therapy of acute ischemic stroke:report of the Standards of Practice Committee of the Society of NeuroInterventional Surgery[J]. J Neurointerv Surg, 2012, 4(2):87-93.
|
| 2. |
Rha JH, Saver JL. The impact of recanalization on ischemic stroke outcome:a meta-analysis[J]. Stroke, 2007, 38(3):967-973.
|
| 3. |
Albers GW, Amarenco P, Easton JD, et al. Antithrombotic and thrombolytic therapy for ischemic stroke:the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy[J]. Chest, 2004, 126(3 Suppl):483S-512S.
|
| 4. |
Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group[J]. N Engl J Med, 1995, 333(24):1581-1587.
|
| 5. |
Hacke W, Kaste M, Bluhmki E, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke[J]. N Engl J Med, 2009, 359(13):1317-1329.
|
| 6. |
Molina CA, Saver JL. Extending reperfusion therapy for acute ischemic stroke:emerging pharmacological, mechanical, and imaging strategies[J]. Stroke, 2005, 36(10):2311-2320.
|
| 7. |
IST-3 collaborative group, Sandercock P, Wardlaw JM, et al. The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial[IST-3]):a randomized controlled trial[J]. Lancet, 2012, 379(9834):2352-2363.
|
| 8. |
Ahmed N, Kellert L, Lees KR, et al. Results of intravenous thrombolysis within 4.5 to 6 hours and updated results within 3 to 4.5 hours of onset of acute ischemic stroke recorded in the safe implementation of treatment in stroke international stroke thrombolysis register (SITS-ISTR):an observational study[J]. JAMA Neurol, 2013, 70(7):837-844.
|
| 9. |
Mikulík R, Dufek M, Goldemund D, et al. A pilot study on systemic thrombolysis followed by low molecular weight heparin in ischemic stroke[J]. Eur J Neurol, 2009, 13(10):1106-1111.
|
| 10. |
Zinkstok SM, Vermeulen M, Stam J, et al. A randomised controlled trial of antiplatelet therapy in combination with Rt-PA thrombolysis in ischemic stroke:rationale and design of the ARTIS-Trial[J]. Trials, 2010, 11:51.
|
| 11. |
Parsons M, Spratt N, Bivard A, et al. A randomized trial of tenecteplase versus alteplase for acute ischemic stroke[J]. N Engl J Med, 2012, 366(12):1099-1107.
|
| 12. |
Smadja D, Chausson N, Joux J, et al. A new therapeutic strategy for acute ischemic stroke:sequential combined intravenous tPA-tenecteplase for proximal middle cerebral artery occlusion based on first results in 13 consecutive patients[J]. Stroke, 2011, 42(6):1644-1647.
|
| 13. |
Hacke W, Albers G, Al-Rawi Y, et al. The desmoteplase in acute ischemic stroke trial (DIAS):a phase Ⅱ MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase[J]. Stroke, 2005, 36(1):66-73.
|
| 14. |
Hacke W, Furlan AJ, Al-Rawi Y, et al. Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion-diffusion weighted imaging or perfusion CT (DIAS-2):a prospective, randomised, double-blind, placebo-controlled study[J]. Lancet Neurology, 2009, 8(2):141-150.
|
| 15. |
Sherman DG, Atkinson RP, Chippendale T, et al. Intravenous ancrod for treatment of acute ischemic stroke:the STAT study:a randomized controlled trial[J]. JAMA, 2006, 283(18):2395-2403.
|
| 16. |
Levy DE, Del Zoppo GJ, Demaerschalk BM, et al. Ancrod in acute ischemic stroke:results of 500 subjects beginning treatment within 6 hours of stroke onset in the ancrod stroke program[J]. Stroke, 2009, 40(12):3796-3803.
|
| 17. |
Saqqur M, Uchino K, Demchuk AM, et al. Site of arterial occlusion identified by transcranial Doppler predicts the response to intravenous thrombolysis for stroke[J]. Stroke, 2007, 38(3):948-954.
|
| 18. |
Molina CA, Montaner J, Arenillas JF, et al. Differential pattern of tissue plasminogen activator-induced proximal middle cerebral artery recanalization among stroke subtypes[J]. Stroke, 2004, 35(2):486-490.
|
| 19. |
Riedel CH, Zimmermann P, Jensen-Kondering U, et al. The importance of size:successful recanalization by intravenous thrombolysis in acute anterior stroke depends on thrombus length[J]. Stroke, 2011, 42(6):1775-1777.
|
| 20. |
Rubiera M, Alvarez-Sabín J, Ribo M, et al. Predictors of early arterial reocclusion after tissue plasminogen activator-induced recanalization in acute ischemic stroke[J]. Stroke, 2005, 36(7):1452-1456.
|
| 21. |
Lansberg MG, Straka M, Kemp S, et al. MRI profile and response to endovascular reperfusion after stroke (DEFUSE 2):a prospective cohort study[J]. Lancet Neurology, 2012, 11(10):860-867.
|
| 22. |
Albers GW, Thijs VN, Wechsler L, et al. Magnetic resonance imaging profiles predict clinical response to early reperfusion:the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study[J]. Ann Neurol, 2006, 60(5):508-517.
|
| 23. |
Davis SM, Donnan GA, Parsons MW, et al. Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET):a placebo-controlled randomised trial[J]. Lancet Neurology, 2008, 7(4):299-309.
|
| 24. |
Alexandrov AV, Molina CA, Grotta JC, et al. Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke[J]. N Engl J Med, 2004, 351(21):2170-2178.
|
| 25. |
Molina CA, Barreto AD, Tsivgoulis G, et al. Transcranial ultrasound in clinical sonothrombolysis (TUCSON) trial[J]. Ann Neurol, 2011, 66(1):28-38.
|
| 26. |
Barreto AD, Alexandrov AV. Adjunctive and alternative approaches to current reperfusion therapy[J]. Stroke, 2012, 43(2):591-598.
|
